Paclitaxel, Carboplatin, and Radiation Therapy for Non-Small-Cell Lung Cancer
January 2nd 1998Preclinically, the taxanes appear to potentiate radiation more effectively than do the platinum compounds. In our phase I trial (LUN-17) in patients with advanced non-small-cell lung cancer, we defined the maximum tolerated